What is the safe dosage of vitamin C for patients taking Eliquis (apixaban) 10mg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Safe Vitamin C Dosage for Patients Taking Eliquis (Apixaban) 10mg

For patients taking Eliquis (apixaban) 10mg, a daily vitamin C dosage of 50-100mg is safe for routine supplementation, while doses up to 500mg daily are generally safe for most patients without specific risk factors. 1

Understanding Vitamin C and Apixaban Interaction

Apixaban (Eliquis) is a direct oral factor Xa inhibitor used for anticoagulation. When considering vitamin C supplementation for patients on apixaban, it's important to understand that:

  • There is no direct evidence of a significant interaction between vitamin C and apixaban that would affect morbidity or mortality
  • Standard doses of vitamin C do not appear to interfere with the anticoagulant effect of apixaban
  • Apixaban dosing is primarily adjusted based on age, weight, and renal function rather than vitamin supplementation 1

Recommended Vitamin C Dosing Algorithm for Patients on Apixaban 10mg

  1. For healthy patients on apixaban without additional risk factors:

    • Daily recommended dose: 50-100 mg/day 1
  2. For patients with chronic conditions:

    • Patients with chronic oxidative stress (diabetes mellitus, heart failure, smoking, alcoholism, severe COPD): 200-500 mg/day 1
    • Patients with chronic malabsorption: 200-500 mg/day 1
  3. For patients with acute illness while on apixaban:

    • During critical illness/acute inflammation: 2-3 g/day IV (only under medical supervision) 1
    • Periprocedural for cardiac surgery: 1-2 g/day for 5-7 days IV 1

Special Considerations and Precautions

Monitoring Considerations

  • Routine monitoring of vitamin C levels is not recommended in patients without clinical suspicion of deficiency 1
  • In critically ill patients or those with severe inflammation, interpretation of vitamin C levels is difficult due to rapid decline with inflammation 1

Risk Assessment

  • High-dose vitamin C (>1g/day) should be used with caution in patients on anticoagulants due to theoretical concerns about altered drug metabolism
  • Patients with renal impairment on apixaban may require dose adjustments of apixaban itself (2.5mg twice daily if meeting specific criteria) 1, but standard vitamin C dosing is generally acceptable

Common Pitfalls to Avoid

  1. Avoid extremely high doses of vitamin C (>3g/day) in patients on anticoagulation without specific medical indication and supervision
  2. Don't overlook underlying conditions that might affect vitamin C requirements or metabolism
  3. Be cautious with IV administration of vitamin C in patients on anticoagulation - dilute with normal saline or glucose to minimize adverse reactions 1
  4. Remember that apixaban dosing may need adjustment based on age ≥80 years, body weight ≤60 kg, or serum creatinine ≥1.5 mg/dL 1, not due to vitamin C supplementation

Conclusion for Clinical Practice

For most patients taking apixaban 10mg, standard vitamin C supplementation of 50-100mg daily is safe. For those with chronic conditions that increase oxidative stress, doses up to 500mg daily are appropriate. Higher doses should only be used for specific medical indications under proper supervision.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.